Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04589442 · ClinicalTrials.gov registry record · Phase 4
Microsurfaced Grafts in Deep Burn Wounds
A Phase 4 study of Burns and Wound Heal, sponsored by CellTherX.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT04589442 is a Phase 4 study of Burns and Wound Heal that is actively recruiting participants, run by CellTherX. The registered enrollment target is 20 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04589442, a Phase 4 study of Burns and Wound Heal, is actively recruiting participants, sponsored by CellTherX.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to wound bed preparedness through 6 weeks (Part A) and wound site healing, graft take and long-term scar outcomes (Part B). Subjects will be treated with both control and microsurfaced cadaveric grafts on adjacent deep-partial or full-thickness burn wounds.
Conditions Studied
Interventions
- BIOLOGICAL Split thickness skin graft
- BIOLOGICAL microsurfaced split thickness skin graft
Study Locations (1)
Georgia
- Joseph M Still Research Foundation - Augusta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-01-04 |
| Est. Completion | 2021-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04589442
The ClinicalTrials.gov registry entry for NCT04589442 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (76% lower). The listed sponsor is CellTherX, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Split thickness skin graft is the first listed.
NCT04589442 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT04589442 about?
NCT04589442 is a clinical study titled "Microsurfaced Grafts in Deep Burn Wounds". This study is designed as a prospective, randomized, within subject controlled design to evaluate the effectiveness of Microsurfaced vs Control cadaveric grafts for coverage of acute deep-partial or full-thickness burn wounds to promote wound healing. This study will be performed in 2 parts: Time to...
What is the current status of trial NCT04589442?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2021-01-04. Estimated completion is 2021-12.
What conditions does trial NCT04589442 study?
This clinical trial studies the following conditions: Burns, Wound Heal.
What interventions are being tested in trial NCT04589442?
The interventions under investigation include: Split thickness skin graft (BIOLOGICAL), microsurfaced split thickness skin graft (BIOLOGICAL).
Who is sponsoring clinical trial NCT04589442?
This trial is sponsored by CellTherX, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04589442 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Comparison of Wound Bed Establishment in Facial Burns
COMPLETED · Phase 4
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.